Objectives of Paris Anti-Obesity Therapies 2006 :

Obesity is an universally spreaded disease, that concerns not only adults but also children and adolescents. In front of the worlwide epidemy announced by the specialists in this field, Paris Anti-Obesity Therapies 2006 proposes to discuss on the latest therapeutical innovations, the new pathways which will allow the development of new pharmaceutical treatments and the use of natural ingredients to fight against obesity .

Targeted audience :

The Paris Anti-Obesity Therapies 2006 conference targets researchers and academic professors, R&D departments, clinicians, pharmaceutical companies, food supplement companies, cosmetics companies, veterinary medicine companies, marketing departments, investors, start ups and actors of the economic evironnment.

Important dates:

  • Conference: Thursday May 18 – Friday May 19, 2006
  • Abstract submission: April 15, 2006
  • Early registration fee payment: before March 17, 2006

Thematic Areas

  • Economic Impact of Anti-Obesity Drugs
  • An Overview on Obesity
  • Childhood Obesity: first step of a future epidemic?
  • Obesity in animals
  • What are the role of circadian clock and stress factors in the management of Obesity ?
  • Current Pharmacotherapies and New Drugs in Developpment
  • Targeting the Energy Intake and Expenditure Balance
  • Targeting the Lipid and Carbohydrate Metabolism
  • Bariatric surgery
  • Dietary Calcium Intake, Dairy Products and Obesity: Overview and Perspectives
  • Sugar and Obesity: Friends or Foes?
  • Latest Advances, Clinical Studies and Scientific Credibility of Ingredient Supplemented Food in the Fight Against Obesity. (Examples of
  • supplements: fibers, vegetal sterols, CLA, cinnamon, chromium and fenugreek) Interesting Molecular Targets: the Peroxisome Proliferator
  • Activated Receptors (PPARs)
  • New Targets Rising from RNAi
  • Inflammation and Obesity: a New Field for Therapy?
  • Role of Mitochondria and Uncoupling Proteins in Obesity and Insulin Resistance
  • Conjugated Linoleic Acid (CLA): Overview and Latest Advances
  • Potential Use of Natural Antioxidants in the Treatment of Obesity
  • Dietary Supplements and Body-Weight Reduction
  • Point of View of an Industrialist in the Natural Ingredient Field: What are the Perspectives and the Latest developments for the Market of
  • Natural Appetite Suppressants
  • Point of View of a Medical Doctor: What is the Efficiency of Natural Ingredients Against Obesity

Scientific committee

  • Dr Christophe Blanckaert (France)
  • Dr Christian Broberger (Sweden)
  • Dr Cathy Chan (Canada)
  • Pr Michael Czech (USA)
  • Dr Jérome Dargent (France)
  • Dr Marvin Edeas (France)
  • Dr Edzard Ernst (United Kingdom)
  • Dr Alain Geloën (France)
  • Dr Paul Goetz (France)
  • Pr Vojtech Hainer (Czech Republic)
  • Pr Rüdiger von Kries (Germany)
  • Dr Bernard Schmitt (France)
  • Dr Yuguang Shi (USA)
  • Pr Bart Staels (France)
  • Dr Fred Turek (USA)
  • Pr Olivier Ziegler (France)

Chairman organizing comittee:

Dr Marvin Edeas, President of the Société Française des Antioxidants.

Abstracts

The abstract should be a one-page document, character times 12-single spacing. The title (in bold) should be typed in capital letters authors initial, surname, institution, state. Underline the name of the presenting author. The text should clearly state objectives, methodology, results, and conclusion. Simple tables and graphs are allowed. Presentation of every communication at the Conference is subjected to formal registration of at least one co-author. All accepted abstracts will be printed in the Abstract Book distributed during the Conference.

Three special oral presentation sessions selected upon abstract submission: for scientists, pharmaceutical laboratories, veterinarian health companies, food supplement companies and start-ups :

  • What are the new scientific insights in the obesity field?
  • What are the potential new targets and useful pathways for new therapies against obesity?
  • What are the latest innovations in the natural ingredients and natural products field to fight or prevent obesity?

Dead line for the submission abstracts : April 15, 2006.
Please indicate in which session you would like to present your data
 Abstracts can be sent as a word file to the following address: anti-obesity2006@wanadoo.fr

Short oral communications for scientists

Based on the abstracts, oral presentations (5 min) will be selected by the scientific committee.

Short oral communications for companies and start-ups

Based on the abstracts, oral presentations (5 min) will be selected by the scientific committee.

Poster Session

  • Posters will be selected by the scientific committee.
  • Poster format: 0.70 width x 1 m high.

Edition of an abstract book

Abstracts of the latest scientific advances on therapies against obesity will be published in an abstract book.

Continuous Medical Education (CME) & Certificate delivery

Paris Anti-Obesity Therapies 2006 will provide 20 CME credits. At your request, you will receive an agreement form.

Certificate delivery

A participation certificate will be delivered to the attendees at the issue of the conference, attesting their presence at the Pasteur Institute for Paris Anti-Obesity Therapies 2006.

Organisation

Scientific contact :

Société Française des Antioxydants - Dr Sandra Huguenin
15 rue de la Paix
75002 Paris
France
Tel : 33 1 55 04 77 55
Fax : 33 1 55 04 77 57
anti-obesity2006@wanadoo.fr

Anti-Obesity Therapies 2006 Innovation Award

The scientific committee will name the most innovative project upon oral or poster presentation. For more information, please contact the scientific committee at anti-obesity2006@wanadoo.fr.